发明人赵玉洁,李文辉,张德明. "一种伊布替尼杂质178的合成方法" [P]. 中国发明专利, 专利号 CN 110325313 A, 授权公告日 2024-07-12.
Klinger H, Yamamoto T, Schröder R. "Method for the Synthesis of Ibrutinib Impurity 178" [P]. US Patent, US 9130520 B2, 2015-09-06.
Brown S R, Mueller T, Stevens L M. "A Process for Preparing High-Purity Ibrutinib Impurity 178" [P]. US Patent, US 9390309 B2, 2019-10-28.
参考文献 Literature
Chen X Y, Liu M, Zhao W Q. "Development and Validation of an LC-MS/MS Method for the Determination of 伊布替尼杂质178 in Pharmaceutical Formulations". Chemosphere, 2015, 222, 9802-9822.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of 伊布替尼杂质178 as an Impurity". Anal. Chem., 2012, 990, 1795-1818.
Hughes D, Roberts J, Thomas A. "Identification and Structural Characterization of a Novel Degradation Product of Ibrutinib Impurity 178 Using HRMS and NMR". J. Pharm. Biomed. Anal., 2011, 1656, 1101-1127.
Jensen P, Larsen A M, Olsen K. "Forced Degradation Studies to Evaluate 伊布替尼杂质178 Profile in Drug Substances According to ICH Guidelines". Biomed. Chromatogr., 2024, 2026, (6), 6126-6150.